{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T13:31:58Z","timestamp":1781530318275,"version":"3.54.1"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T00:00:00Z","timestamp":1583452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2020.00165","type":"journal-article","created":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T09:37:36Z","timestamp":1583487456000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":31,"title":["Activation of BK Channels Prevents Hepatic Stellate Cell Activation and Liver Fibrosis Through the Suppression of TGF\u03b21\/SMAD3 and JAK\/STAT3 Profibrotic Signaling Pathways"],"prefix":"10.3389","volume":"11","author":[{"given":"Linli","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael X.","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunyan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Gang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangwei","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,3,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1385\/1-59259-940-0-237","article-title":"Modeling liver fibrosis in rodents.","volume":"117","author":"Constandinou","year":"2005","journal-title":"Methods Mol. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1111\/liv.12681","article-title":"K(+)-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells.","volume":"35","author":"Freise","year":"2015","journal-title":"Liver Int."},{"key":"B3","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nrgastro.2010.97","article-title":"Evolving challenges in hepatic fibrosis.","volume":"7","author":"Friedman","year":"2010","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B4","doi-asserted-by":"crossref","first-page":"10756","DOI":"10.1016\/S0021-9258(18)81686-6","article-title":"Maintenance of differentiated phenotype of cultured rat hepatic lipocytes by basement membrane matrix.","volume":"264","author":"Friedman","year":"1989","journal-title":"J. Biol. Chem."},{"key":"B5","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/s0168-8278(01)00198-2","article-title":"Human myofibroblastic hepatic stellate cells express Ca(2+)-activated K(+) channels that modulate the effects of endothelin-1 and nitric oxide.","volume":"35","author":"Gasull","year":"2001","journal-title":"J. Hepatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"4975","DOI":"10.1096\/fj.13-235176","article-title":"Treatment of experimental asthma using a single small molecule with anti-inflammatory and BK channel-activating properties.","volume":"27","author":"Goldklang","year":"2013","journal-title":"FASEB J."},{"key":"B7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1006\/bbrc.1994.1199","article-title":"Rottlerin, a novel protein kinase inhibitor.","volume":"199","author":"Gschwendt","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/srep23417","article-title":"Human EAG channels are directly modulated by PIP2 as revealed by electrophysiological and optical interference investigations.","volume":"6","author":"Han","year":"2016","journal-title":"Sci. Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1080\/21691401.2019.1615931","article-title":"Parathyroid hormone-related protein activates HSCs via hedgehog signalling during liver fibrosis development.","volume":"47","author":"He","year":"2019","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","article-title":"Pathogenesis of liver fibrosis.","volume":"6","author":"Hernandez-Gea","year":"2011","journal-title":"Annu. Rev. Pathol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","article-title":"Hepatic stellate cells as key target in liver fibrosis.","volume":"121","author":"Higashi","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B12","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1152\/physiol.00055.2012","article-title":"Transduction of voltage and Ca2+ signals by Slo1 BK channels.","volume":"28","author":"Hoshi","year":"2013","journal-title":"Physiology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1093\/abbs\/gmx118","article-title":"Smad3-STAT3 crosstalk in pathophysiological contexts.","volume":"50","author":"Itoh","year":"2018","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"B14","doi-asserted-by":"publisher","first-page":"E3297","DOI":"10.1073\/pnas.1400062111","article-title":"Origin of myofibroblasts in the fibrotic liver in mice.","volume":"111","author":"Iwaisako","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1172\/JCI88881","article-title":"Liver inflammation and fibrosis.","volume":"127","author":"Koyama","year":"2017","journal-title":"J. Clin. Invest."},{"key":"B16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1152\/physrev.00001.2016","article-title":"Molecular determinants of BK channel functional diversity and functioning.","volume":"97","author":"Latorre","year":"2017","journal-title":"Physiol. Rev."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055979","article-title":"PKCdelta as a regulator for TGFbeta1-induced alpha-SMA production in a murine nonalcoholic steatohepatitis model.","volume":"8","author":"Lee","year":"2013","journal-title":"PLoS One"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3823","article-title":"Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology.","volume":"4","author":"Mederacke","year":"2013","journal-title":"Nat. Commun."},{"key":"B19","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s40139-014-0052-50","article-title":"The mechanisms of HSC activation and epigenetic regulation of HSCs phenotypes.","volume":"2","author":"Page","year":"2014","journal-title":"Curr. Pathobiol. Rep."},{"key":"B20","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1136\/gut.50.4.571","article-title":"Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension.","volume":"50","author":"Reynaert","year":"2002","journal-title":"Gut"},{"key":"B21","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/j.1478-3231.2008.01668.x","article-title":"Large-conductance calcium-activated potassium channels modulate vascular tone in experimental cirrhosis.","volume":"28","author":"Rodriguez-Vilarrupla","year":"2008","journal-title":"Liver Int."},{"key":"B22","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.matbio.2018.04.006","article-title":"Liver fibrosis: direct antifibrotic agents and targeted therapies.","author":"Schuppan","year":"2018","journal-title":"Matrix Biol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jhep.2017.11.012","article-title":"Determinants of fibrosis progression and regression in NASH.","volume":"68","author":"Schuppan","year":"2017","journal-title":"J. Hepatol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/nm1663","article-title":"TLR4 enhances TGF-beta signaling and hepatic fibrosis.","volume":"13","author":"Seki","year":"2007","journal-title":"Nat. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/hep.27332","article-title":"Hepatic inflammation and fibrosis: functional links and key pathways.","volume":"61","author":"Seki","year":"2015","journal-title":"Hepatology"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/srep28770","article-title":"The calcium-activated potassium channel KCa3.1 is an important modulator of hepatic injury.","volume":"6","author":"Sevelsted Moller","year":"2016","journal-title":"Sci. Rep."},{"key":"B27","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s00535-017-1404-1404","article-title":"Human hepatic stellate cell isolation and characterization.","volume":"53","author":"Shang","year":"2018","journal-title":"J. Gastroenterol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.tips.2007.07.003","article-title":"Rottlerin: an inappropriate and ineffective inhibitor of PKCdelta.","volume":"28","author":"Soltoff","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"4302","DOI":"10.1074\/jbc.M116.773085","article-title":"Transforming growth factor-beta (TGF-beta) directly activates the JAK1-STAT3 Axis to induce hepatic fibrosis in coordination with the SMAD pathway.","volume":"292","author":"Tang","year":"2017","journal-title":"J. Biol. Chem."},{"key":"B30","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s00424-013-1359-1350","article-title":"MaxiK channel and cell signalling.","volume":"466","author":"Toro","year":"2014","journal-title":"Pflugers Arch."},{"key":"B31","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1016\/j.jhep.2015.02.039","article-title":"Hepatic fibrosis: concept to treatment.","volume":"62","author":"Trautwein","year":"2015","journal-title":"J. Hepatol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation.","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1136\/gutjnl-2016-313392","article-title":"The HLF\/IL-6\/STAT3 feedforward circuit drives hepatic stellate cell activation to promote liver fibrosis.","volume":"67","author":"Xiang","year":"2018","journal-title":"Gut"},{"key":"B34","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1136\/gut.2004.042127","article-title":"Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis.","volume":"54","author":"Xu","year":"2005","journal-title":"Gut"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.00165\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T21:56:51Z","timestamp":1614722211000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.00165\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,6]]},"references-count":34,"alternative-id":["10.3389\/fphar.2020.00165"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2020.00165","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,6]]},"article-number":"165"}}